WO2002016578A3 - Secreted proteins and methods of using same - Google Patents

Secreted proteins and methods of using same Download PDF

Info

Publication number
WO2002016578A3
WO2002016578A3 PCT/US2001/022598 US0122598W WO0216578A3 WO 2002016578 A3 WO2002016578 A3 WO 2002016578A3 US 0122598 W US0122598 W US 0122598W WO 0216578 A3 WO0216578 A3 WO 0216578A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
same
secreted proteins
useful
nucleic acids
Prior art date
Application number
PCT/US2001/022598
Other languages
French (fr)
Other versions
WO2002016578A2 (en
Inventor
Eric Wen Su
He Wang
Yu Zhi
Original Assignee
Lilly Co Eli
Eric Wen Su
He Wang
Yu Zhi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Eric Wen Su, He Wang, Yu Zhi filed Critical Lilly Co Eli
Priority to AU2001284651A priority Critical patent/AU2001284651A1/en
Priority to US10/343,953 priority patent/US20030212258A1/en
Priority to EP01963725A priority patent/EP1313765A2/en
Publication of WO2002016578A2 publication Critical patent/WO2002016578A2/en
Publication of WO2002016578A3 publication Critical patent/WO2002016578A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Abstract

The present invention provides nucleic acid sequences encoding novel human proteins. These novel nucleic acids are useful for constructing the claimed DNA vectors and host cells of the invention and for preparing the claimed nucleic acids, recombinant proteins and antibodies that are useful in the claimed methods and medical uses.
PCT/US2001/022598 2000-08-24 2001-08-17 Secreted proteins and methods of using same WO2002016578A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2001284651A AU2001284651A1 (en) 2000-08-24 2001-08-17 Secreted proteins and methods of using same
US10/343,953 US20030212258A1 (en) 2001-08-17 2001-08-17 Novel secreted proteins and methods of using same
EP01963725A EP1313765A2 (en) 2000-08-24 2001-08-17 Secreted proteins and methods of using same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22769700P 2000-08-24 2000-08-24
US60/227,697 2000-08-24

Publications (2)

Publication Number Publication Date
WO2002016578A2 WO2002016578A2 (en) 2002-02-28
WO2002016578A3 true WO2002016578A3 (en) 2003-01-16

Family

ID=22854119

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/022598 WO2002016578A2 (en) 2000-08-24 2001-08-17 Secreted proteins and methods of using same

Country Status (3)

Country Link
EP (1) EP1313765A2 (en)
AU (1) AU2001284651A1 (en)
WO (1) WO2002016578A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008332B2 (en) 2006-05-31 2011-08-30 Takeda San Diego, Inc. Substituted indazoles as glucokinase activators
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
US8124617B2 (en) 2005-09-01 2012-02-28 Takeda San Diego, Inc. Imidazopyridine compounds
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007198A2 (en) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Dna sequences and secreted proteins encoded thereby
WO1999056763A1 (en) * 1998-05-07 1999-11-11 The Regents Of The University Of California Use of neglected target tissue antigens in modulation of immune responses
WO2001079454A1 (en) * 2000-04-13 2001-10-25 Smithkline Beecham Corporation Novel compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007198A2 (en) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Dna sequences and secreted proteins encoded thereby
WO1999056763A1 (en) * 1998-05-07 1999-11-11 The Regents Of The University Of California Use of neglected target tissue antigens in modulation of immune responses
WO2001079454A1 (en) * 2000-04-13 2001-10-25 Smithkline Beecham Corporation Novel compounds

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 7 January 1998 (1998-01-07), LAMERDIN, J.E. ET AL.: "Homo sapiens chromosome 19, cosmid R26624 (LLNLR-226B12), complete sequence.", XP002199809, Database accession no. AC003967 *
KLEIN R D ET AL: "SELECTION FOR GENES ENCODING SECRETED PROTEINS AND RECEPTORS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 14, 9 July 1996 (1996-07-09), pages 7108 - 7113, XP002061411, ISSN: 0027-8424 *
YOKOYAMA-KOBAYASHI M ET AL: "A signal sequence detection system using secreted protease activity as an indicator", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 163, no. 2, 3 October 1995 (1995-10-03), pages 193 - 196, XP004041983, ISSN: 0378-1119 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124617B2 (en) 2005-09-01 2012-02-28 Takeda San Diego, Inc. Imidazopyridine compounds
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
US8008332B2 (en) 2006-05-31 2011-08-30 Takeda San Diego, Inc. Substituted indazoles as glucokinase activators
US8394843B2 (en) 2006-05-31 2013-03-12 Takeda California, Inc. Substituted isoindoles as glucokinase activators
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators

Also Published As

Publication number Publication date
AU2001284651A1 (en) 2002-03-04
WO2002016578A2 (en) 2002-02-28
EP1313765A2 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
WO2002014358A3 (en) Novel secreted proteins and their uses
WO2002008277A3 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
WO1999031236A3 (en) EXTENDED cDNAs FOR SECRETED PROTEINS
WO2001000806A3 (en) Dna's encoding proteins with signal peptides
WO2000006736A3 (en) Nucleic acids and proteins from group b streptococcus
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
WO2001032882A3 (en) Nucleic acids and proteins from group b streptococcus
WO2002032939A3 (en) Secreted proteins and their uses
WO2001087978A3 (en) Human abc transporter and its use
WO2002026801A3 (en) Secreted proteins and their uses
WO2002048361A3 (en) Novel secreted proteins and their uses
WO2002016578A3 (en) Secreted proteins and methods of using same
WO2001092493A3 (en) 21956 and 25856, human aminopeptidases and uses thereof
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2002090500A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2002012475A3 (en) C1q-related factor, homologous polypeptides and therapeutic uses thereof
EP1529843A3 (en) Novel secreted proteins and their uses
WO2003029778A3 (en) Novel secreted proteins and their uses
WO2002074960A3 (en) 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
WO2004013281A3 (en) Novel proteins and their uses
WO2002046408A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2002048187A3 (en) Secretion signal peptides, their dna sequences, expression vectors for eukaryotic cells that can be produced with the same, and use thereof for biotechnological production of proteins
WO2003083048A3 (en) Novel secreted proteins and their uses
WO2004087886A3 (en) Modified adenoviral e1a constructs and methods of use thereof
WO2002016579A3 (en) Nucleic acids, vectors, host cells, polypeptides and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10343953

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2001963725

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001963725

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001963725

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP